Trend analysis of gastric cancer and colorectal cancer mortality in Iran, 1995-2003

Iranian Journal of Cancer Prevention

Volumn 4, Issue 1, 2011, Pages 38-43

  Pourhoseingholi, M A ^a   Faghihzadeh, S ^b   Hajizadeh, E ^b   Gatta, G ^c   Zali, M R ^a   Abadi, A R ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Colorectal cancer; Gastric cancer; Iran; Mortality; Trend analysis

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER REGISTRY; CANCER RESEARCH; CANCER STATISTICS; CAUSE OF DEATH; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PUBLIC HEALTH PROBLEM; SEX DIFFERENCE; STOMACH CANCER; TREND STUDY;

EID: 79551493558     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Naghavi M. Death report from 23 provinces in Iran. 1st edition. 2004; Ministry of Health and Medical Education; Tehran.
2. Mosavi-Jarrahi A, Mohagheghi MA. Epidemiology of esophageal cancer in the high-risk population of Iran. Asian Pac J Cancer Prev. 2006; 7, 375-80.
3. Cancer incidence in the Tehran Metropolitan. Second report of the Tehran Population-Based cancer registry, the cancer Institute cancer research centre. 2007.
4. Moghimi-Dehkordi B, Safaee A, Zali MR. Comparison of colorectal and gastric cancer: survival and prognostic factors. Saudi J Gastroenterol. 2009 Jan; 15(1):18-23.
5. Samarasam I, Chandran BS, Sitaram V, Perakath B, Nair A, Mathew G. Palliative gastrectomy in advanced gastric cancer: is it worthwhile? ANZ J Surg. 2006; 76(1-2):60-3.
6. Murray CJ, Lopez AD. Alternate projections of mortality and disability by cause 1999-2020: global burden of disease study. Lancet. 1997; 349, 1498-1504.
7. Ozkan K, Turkkan E, Ender K, Mutlu D, Murat A, Nalan B, et al. 5-Fluorouracil, epirubicin and cisplatin in the treatment of metastatic gastric carcinoma: a retrospective analysis of 68 patients. Indian J Cancer. 2005; 42(2):85-8.
8. Pourhoseingholi MA, Hajizadeh E, Moghimi Dehkordi B, Safaee A, Abadi A, Zali MR. Comparing Cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev. 2007 Jul-Sep; 8(3):412-6.
9. Moghimi-Dehkordi B, Safaee A, Pourhoseingholi MA, Zali MR. Effect of demographic and clinicopathologic factors on prognosis of early gastric cancer in Iran. Asian Pac J Cancer Prev. 2008 Oct-Dec; 9(4):585-8.
10. Pourhoseingholi MA, Moghimi-Dehkordi B, Safaee A, Hajizadeh E, Solhpur A, Zali MR. Prognostic factors in gastric cancer using log-normal censored regression model. Indian J Med Res. 2009 Mar; 129(3):262-7.
11. Pourhoseingholi MA, Vahedi M, Moghimi-Dehkordi B, Pourhoseingholi A, Ghafarnejad F, Maserat E, et al. Burden of hospitalization for gastrointestinal tract cancer patients - Results from a cross-sectional study in Tehran. Asian Pac J Cancer Prev. 2009; Jan-Mar; 10(1):107-10.
12. Sonnenberg A, Delcò F, Inadomi JM. Costeffectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 200; 17; 133(8):573-84.
13. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001, 2:533-43.
14. Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis. 2008 Jul; 23(7):683-8.
15. Azadeh S, Moghimi-Dehkordi B, Fatemi SR, Pourhoseingholi MA, Ghiasi S, Zali MR. Colorectal cancer in Iran: an epidemiological study. Asian Pac J Cancer Prev. 2008 Jan-Mar; 9(1):123-6.
16. Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP. Years of life lost (YLL) from cancer is an important measure of population burden - and should be considered when allocating research funds British Journal of Cancer. 2005; 92, 241-5.
17. Naghavi M. Death report from 18 provinces in Iran. 1st edition. 2002; Ministry of Health and Medical Education, Tehran, Iran.
18. Naghavi M. Death report from 18 provinces in Iran. 1st edition. 2003; Ministry of Health and Medical Education, Tehran, Iran.
19. National Statistics Center, Online Publications at: http://amar.sci.org.ir/PlanList.aspx.
20. Levi F, Lucchini F, La Vecchia C, Negri E. Trends in mortality from cancer in European Union, 1955-94. Lancet.1999; 354:742-3.
21. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer. 2004; 110:155-169.
22. Parkin DM. International variation. Oncogene. 2004; 23(38):6329-40.
23. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekzadeh R, Donald Maxwell P. Cancer occurrence in Iran in 2002, an international prospective. Asian Pacific J Cancer Prev. 2005; 6: 359-63.
24. Somi MH, Farhang S, Mirinezhad SK, Naghashi S, Sief-Farshad M, Golzari M. Cancer in East Azerbaijan, Iran: Results of a Population-based Cancer Registry. Asian Pac J Cancer Prev. 2008; 9:327-30.
25. Malekzadeh R, Nasseri-Moghaddam S. Reducing gastric cancer mortality in developing countries: learning from the experience in Japan. Arch Iran Med. 2008 Sep; 11(5):588-90.
26. Moghimi-Dehkordi B, Safaee A, Zali MR. Survival rates and prognosis of gastric cancer using an actuarial life-table method. Asian Pac J Cancer Prev. 2008 Apr- Jun; 9(2):317-21.
27. Movahedi M, Afsharfard A, Moradi A, Naser Moadeli A, Khoshnevis J, Fattahi F, Akbari ME. Survival rate of gastric cancer in Iran. JRMS. 2009; 14 (6):367-73.
28. Mehrabian AA, Esna-Ashari F, Zham H, Hadizadeh M, Bohlooli M, Khayamzadeh M, Akbari ME. Gastric Cancer Prevalence, According To Survival Data in Iran (National Study-2007). Iranian J Publ Health.2010; 39(3): 27-31.
29. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin. 2005;55:74-108.
30. Verdecchia A, Mariotto A, Gatta G, Bustamante-Teixeira MT, Ajiki W. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer. 2003; 39:1603-9.
31. Fuchs CS, Mayer RJ. Gastric carcinoma. Engl J Med 1995; 333:32-41.
32. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006 Jan 7; 12(1):17-20.
33. Matsuzaka M, Fukuda S, Takahashi I, Shimaya S, Oyama T, Yaegaki M, et al. The decreasing burden of gastric cancer in Japan. Tohoku J Exp Med. 2007 Jul; 212(3):207-19.
34. Winawer SJ. Gastric cancer: Worldwide burden and prevention opportunities. Chin J Dig Dis. 2005; 6(3):107-9.
35. Mousavi SM, Somi MH. Gastric Cancer in Iran 1966-2006. Asian Pacific J Cancer Prev. 2009; 10, 407-12.
36. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: the global picture. Eur J Cancer. 2001; 37(suppl 8):S4-S66.
37. Fernandez E, La Vecchia C, Gonzalez JR, Lucchini F, Negri E, Levi F. Converging patterns of CR mortality in Europe. Eur J Cancer 2005; 41:430-437.
38. Valean S, Mircea PA, Oprea L, Frentiu D, Popescu G, Nagy G, et al. Trends of mortality rates from gastric cancer and colorectal cancer in Romania 1955-2003. J Gastrointestin Liver Dis. 2006 Jun; 15(2):111-5.
39. Center for Disease Control and Prevention, Noncommunicable Deputy Cancer Office. Iranian Annual National Cancer Registration Report 2005 - 2006[in Persian]. Tehran (Iran): Ministry of Health and Medical Education; 2007.
40. Hosseini SV, Izadpanah A, Yarmohammadi H. Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980-2000. ANZ J Surg. 2004; 74:547-9.
41. Moradi A, Khayamzadeh M, Guya MM, Mirzaei HR, Salmanian R, Rakhsha A, Akbari ME. Survival of colorectal cancer in Iran. Asian Pac J Cancer Prev. 2009 Oct-Dec; 10(4):583-6.
42. Esna-Ashari F, Sohrabi MR, Abadi AR, Mehrabian AA, Mofid B, Bohluli M, Akbari ME. Colorectal Cancer Prevalence According to Survival Data in Iran-2007. IJCP 2009; 2(1): 15-8.
43. Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R. Epidemiology and molecular genetics of colorectal cancer in Iran: a review. Arch Iran Med. 2009 Mar; 12(2):161-9.
44. Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, Bishehsari F, et al. Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett. 2006; 240:143-7.